Neuronoff
Manufacturing · Ohio, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
11000 Cedar Ave Ste 290, Cleveland, Ohio...Phone Number
(216) 206-7726Website
www.neuronoff.comRevenue
$9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Neuronoff
Neuronoff offers the Injectrode® Platform, a solution designed to provide chronic pain patients with relief without the need for drugs or invasive surgeries. The platform involves a simple needle-based placement of the device that creates a low impedance path for electrical signals to alleviate pain. Neuronoff aims to replace repeat drug injections with this innovative approach, offering a more accessible and effective pain management solution for patients with chronic pain.Explore more
Neuronoff Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Neuronoff your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Neuronoff has recently received funding, and reach out quickly before it becomes old news!
Neuronoff, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Neuronoff recently announced quarterly report
Product Launch: Get notified when Neuronoff launches new products
Congratulate Masked Content for being promoted to Masked Content at Neuronoff
Funding: Get notified immidiatlly once Neuronoff has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Neuronoff is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Neuronoff had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Neuronoff as Masked Content
Find more new buyers
Compare Similar Companies to Neuronoff
Compare insights from companies similar to Neuronoff, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$9.3M
11-50
Private
$115M
2010
AK
Alexander KhairkhahanInventor, Founder, Chief Operating Officer, General Manager
Company Profile Activity
Activity Insights
Neuronoff is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Neuronoff is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Neuronoff.
Neuronoff financials insights
Gather financial insights about Neuronoff, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Multiple Rounds
$12.2M
Neuronoff Tech Stack
A closer look at the technologies used by Neuronoff
Most Recent Scoops
Funding
Funding
Funding
Funding
Funding
Funding
Funding
Project
Award, Spending/Investment
Neuronoff News & Media
Neuronoff Demonstrates Multi-Site IPG Compatibility for Injectrode® Platform, Expanding Neuromodulation Beyond Spinal Cord Stimulation
Needle-Delivered Tripolar Electrode Connects to Standard IPG Connectors; Selectively Stimulates Lumbar DRG, Peripheral Nerve, and Sacral Targets from Single Implantable Pulse Generator CLEVELAND, March 16, 2026 /PRNewswire/ -- Neuronoff, Inc., a clinical-stage neuromodulation company,...Neuronoff raises $4.5 million to bring needle-based chronic pain treatment to market
Cleveland-based Neuronoff raised $4.5M to bring its Injectrode—an injectable, minimally invasive chronic pain treatment—to market by 2026, offering a drug-free, surgery-free alternative to traditional neuromodulation therapies.Neuronoff Closes Oversubscribed $4.5M Round to Prepare Launch of Injectrode Platform for Chronic Pain
CLEVELAND, Oct. 8, 2025 /PRNewswire/ -- Neuronoff, Inc., a clinical-stage medical device company pioneering minimally invasive pain treatments, today announced the closure of an oversubscribed $4.5 million financing round to advance its Injectrode® platform toward FDA clearance and...Neuronoff Secures $5 Million in DOD and NIH Funding to Advance Minimally Invasive Neuromodulation Platform
CLEVELAND, Jan. 30, 2025 /PRNewswire/ -- Neuronoff, Inc., a pioneer in minimally invasive neuromodulation solutions, today announced two major funding milestones totaling $5 million to advance its innovative Injectrode® technology. The Department of Defense (DOD) has recommended $1.73...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neuronoff
Sign Up For FreeTo access detailed company insights
Neuronoff offers the Injectrode® Platform, a solution designed to provide chronic pain patients with relief without the need for drugs or invasive surgeries. The platform involves a simple needle-based placement of the device that creates a low impedance path for electrical signals to alleviate pain. Neuronoff aims to replace repeat drug injections... Read More
